Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab Emirates
Open Access
- 29 January 2008
- journal article
- research article
- Published by Springer Nature in BMC Nephrology
- Vol. 9 (1) , 1
Abstract
Microalbuminuria (MA) represents the earliest clinical evidence of diabetic nephropathy and is a predictor of increased cardiovascular morbidity and mortality. The aim of this study was to determine the prevalence of MA among diabetic patients in the Al-Ain district of the United Arab Emirates (UAE).Keywords
This publication has 42 references indexed in Scilit:
- Evaluation of tests for microalbuminuria screening in patients with diabetesNephrology Dialysis Transplantation, 2005
- Is Increasing Urinary Albumin a Better Marker for Microvascular than for Macrovascular Complication of Type 2 Diabetes mellitus?Nephron Clinical Practice, 2005
- An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) StudyDiabetologia, 2004
- Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular diseaseKidney International, 2004
- Diabetic Kidney Disease: Preventing Dialysis and TransplantationClinical Diabetes, 2003
- Microalbuminuria: is it a valid predictor of cardiovascular risk?Cleveland Clinic Journal of Medicine, 2003
- Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95Journal of Human Hypertension, 2001
- Nephropathy in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 1999
- Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patientsBMJ, 1988
- Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset DiabetesNew England Journal of Medicine, 1984